We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

112 hedge funds and large institutions have $263M invested in BioSpecifics Technologies Corp. in 2019 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 39 increasing their positions, 36 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more capital invested

Capital invested by funds: $247M → $263M (+$16.1M)

8% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 36

0% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 16

2% less funds holding

Funds holding: 114 → 112 (-2)

Holders
112
Holders Change
-2
Holders Change %
-1.75%
% of All Funds
2.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
39
Reduced
36
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Russell Investments Group
Russell Investments Group
United Kingdom
+$5.64M
2
TSW
Thompson Siegel & Walmsley
Virginia
+$3.43M
3
Boston Partners
Boston Partners
Massachusetts
+$2.25M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$1.87M
5
Aviva
Aviva
United Kingdom
+$1.86M

Top Sellers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$6.1M
2
RC
Roubaix Capital
Colorado
-$2.09M
3
TAM
THB Asset Management
Connecticut
-$1.88M
4
RA
Royce & Associates
New York
-$1.64M
5
WCM
Wedge Capital Management
North Carolina
-$1.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
Boston Partners
26
Boston Partners
Massachusetts
$2.42M +$2.25M +42,451 New
Aviva
27
Aviva
United Kingdom
$2M +$1.86M +35,074 New
Citadel Advisors
28
Citadel Advisors
Florida
$1.71M +$441K +8,313 +38%
CCMG
29
Clark Capital Management Group
Pennsylvania
$1.71M +$224K +4,230 +16%
N
30
Nuveen
North Carolina
$1.69M -$971K -18,318 -38%
PPA
31
Parametric Portfolio Associates
Washington
$1.64M +$503K +9,484 +49%
CAM
32
ClariVest Asset Management
California
$1.53M -$632K -11,924 -31%
Squarepoint
33
Squarepoint
New York
$1.51M +$436K +8,220 +45%
WG
34
Winton Group
United Kingdom
$1.5M -$418K -7,890 -23%
OAM
35
Oxford Asset Management
United Kingdom
$1.34M -$203K -3,823 -14%
IP
36
Isthmus Partners
Wisconsin
$1.27M +$7.95K +150 +0.7%
Manulife (Manufacturers Life Insurance)
37
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.24M -$5.41K -102 -0.5%
Invesco
38
Invesco
Georgia
$1.21M -$4.67K -88 -0.4%
DCM
39
Dupont Capital Management
Delaware
$1.16M -$40.8K -770 -4%
TCA
40
Transcend Capital Advisors
New Jersey
$1.12M +$1.04M +19,700 New
MCM
41
Matarin Capital Management
New York
$1.08M -$975K -18,400 -49%
Ameriprise
42
Ameriprise
Minnesota
$1.03M +$13.1K +247 +1%
UBS Group
43
UBS Group
Switzerland
$1.02M +$101K +1,900 +12%
SGI
44
Summit Global Investments
Utah
$1.01M +$92.8K +1,750 +11%
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$994K -$101K -1,906 -10%
Cambridge Investment Research Advisors
46
Cambridge Investment Research Advisors
Iowa
$804K +$748K +14,119 New
Marshall Wace
47
Marshall Wace
United Kingdom
$766K -$182K -3,439 -20%
CEP
48
Chicago Equity Partners
Illinois
$751K -$392K -7,385 -36%
VRS
49
Virginia Retirement Systems
Virginia
$729K +$42.4K +800 +7%
Two Sigma Advisers
50
Two Sigma Advisers
New York
$723K +$265K +5,000 +65%
1
2
3 4 5

BSTC Hedge Fund Activity: Q4 2019 in Review

112 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q4 2019, worth a combined $263M — up 6.5% from $247M a quarter earlier.

Fund positioning in BSTC was balanced in Q4 2019: 16 funds opened new positions, 16 closed out, 39 added to existing stakes and 36 trimmed.

The largest buyer was Russell Investments Group, adding an estimated $5.64M. The largest seller was Acadian Asset Management, exiting entirely with an estimated $6.1M sold.

  • 112 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q4 2019, down from 114 in Q3 2019.
  • Funds reported $263M of BioSpecifics Technologies Corp. stock for Q4 2019, up 6.5% quarter-over-quarter.
  • 16 funds opened new BioSpecifics Technologies Corp. positions in Q4 2019 and 16 closed out, a net change of 0 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q4 2019 was Russell Investments Group, an estimated $5.64M added.
  • The largest BioSpecifics Technologies Corp. seller in Q4 2019 was Acadian Asset Management, an estimated $6.1M sold.

Based on aggregated 13F filings for Q4 2019.